Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.94 CAD | +0.84% | -1.08% | +12.32% |
Apr. 19 | Bausch Health's Issuer Credit Rating Upgraded by S&P | MT |
Apr. 12 | Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says | MT |
Sales 2024 * | 9.39B 12.9B | Sales 2025 * | 9.4B 12.92B | Capitalization | 3.15B 4.33B |
---|---|---|---|---|---|
Net income 2024 * | 218M 300M | Net income 2025 * | 416M 572M | EV / Sales 2024 * | 2.46 x |
Net Debt 2024 * | 19.91B 27.36B | Net Debt 2025 * | 18.33B 25.19B | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
13.8
x | P/E ratio 2025 * |
7.68
x | Employees | 20,270 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc.
1 day | +0.84% | ||
1 week | -1.08% | ||
Current month | -16.79% | ||
1 month | -7.73% | ||
3 months | +9.14% | ||
6 months | +18.92% | ||
Current year | +12.32% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 11.84 | -0.75% | 390,478 |
24-04-17 | 11.93 | -1.16% | 351,688 |
24-04-16 | 12.07 | +1.51% | 399,969 |
24-04-15 | 11.89 | -1.49% | 329,658 |
24-04-12 | 12.07 | -1.71% | 523,572 |
Delayed Quote Toronto S.E., April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- BHC Stock
- BHC Stock